USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Nano-based science paving the precision medicine era
30-Dec-2015
Global
Technology Research
D6C0-01-00-00-00
HC02409-GL-TR_16531
The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.
Innovation in nanomedicine fields has played a major role in the improvement of both length and quality of life during the present decade, appreciably advocated to reduce the disease burden for individuals and the society through completely new or improved diagnostic and therapeutic methods. Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for nanomedicine on precision medicine topics.
Frost & Sullivan (www.frost.com/techvision) identified an unprecedented behavior in terms of innovation in nanomedicine fields, with notable acceptance in diagnostics, therapeutics, companion diagnostics, regenerative medicine, and many other applications that are undoubtedly linked to the concept of precision medicine. Nanomedicine enables personalized medicine approaches in many ways. As an instance, nano-based diagnostic tests or nano-imaging diagnosis may help to the stratification of patients and thereby to guarantee a most personalized, patient-centered therapy. In addition, clinical protocols become simpler, more efficient and less costly.
Research Scope
Research Scope (continued)
Research Methodology
Key Findings
Industry Value Chain and Business Model
Core Technology Applications
Technology Evolution
Core Growth Opportunities
Technology Synergy and Nanobiotechnology
Technology Roadmap
Industry Drivers and Restraints
Industry Technical and Business Challenges
Market Drivers and Restraints
Technology Drivers and Restraints
Porter’s Five Forces Analysis
Nanomedicine Innovation Model
Nanomedicine Innovation Model (continued)
Nanomedicine Innovation Model (continued)
Nanomedicines Application Focus
Nanomedicines Therapeutics Focus
Nanomedicines Diagnostics Focus
Nanomedicines Regenerative Medicine Focus
Nanomedicine Multiple Segmentation
Nanomedicines Principal Industry Facts
Nanomedicines Principal Industry Facts (continued)
Nanomedicine Development Pipeline
Nanomedicine Products by Developmental Phase
Global Nanomedicine Market
Global Nanomedicine Market (continued)
Global Nanomedicine Market (continued)
Product Pipeline
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Product Pipeline (continued)
Nanomedicine Marketed Products
Nanomedicine Marketed Products (continued)
Nanomedicine Marketed Products (continued)
Key Companies in North America
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in North America (continued)
Key Companies in Europe
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Europe (continued)
Key Companies in Asia Pacific
Key Companies in Asia Pacific (continued)
Intellectual Property
Intellectual Property (continued)
Intellectual Property (continued)
Multicriteria Approach for Benchmarking
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Multicriteria Approach for Benchmarking (continued)
Final Remarks
Legal Disclaimer
Key Contacts
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Intellectual Property Sources
Key Patents
Key Patents (continued)
Key Patents (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Cecilia Van Cauwenberghe |
| Industries | Healthcare |
| WIP Number | D6C0-01-00-00-00 |
| Keyword 1 | Nanomedicine |
| Keyword 2 | Nanomedicine Size |
| Keyword 3 | Nanomedicine Trends |
| Is Prebook | No |